IP Library Granted Patent US 10,344,009
Granted Patent B2
US 10,344,009 · App. 15/772,833 · Granted Jul 9, 2019

Process for the preparation of sofosbuvir

Inventors: Sureshbabu Jayachandra (Hyderabad, IN); Vipin Kumar Kaushik (Hyderabad, IN); Vijaya Krishna Ravi (Hyderabad, IN); Vikas Chandra Dev (Hyderabad, IN); Saiprasad Kottolla (Hyderabad, IN); Potla Venkata Srinivasa Rao (Hyderabad, IN); Srinivas Vakiti (Hyderabad, IN); Chaitanya Muggu (Hyderabad, IN); Subramanyam Dandala (Hyderabad, IN)
Assignee: Mylan Laboratories Limited
C07D307/33C07D307/20C07D319/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,344,009
App. No.
15/772,833
Granted
Jul 9, 2019
Kind
B2
Abstract

A process for the preparation of intermediates 9, useful in the synthesis of sofosbuvir, as well as intermediates of formula [12] are disclosed herein.

Claims (23)

1. A process for the preparation of compound of formula 9

comprising the steps of

a) converting a compound of formula 17 to a compound of formula 16;

b) oxidizing the compound of formula 16 to get a compound of formula 15;

c) fluorinating the compound of formula 15 to obtain fluoro sulfate compound of formula 14;

d) hydrolyzing the compound of formula 14 to yield a compound of formula 13;

e) protecting the hydroxyl group of the compound of formula 13 to get a compound of formula 12, and

f) converting the compound of formula 12 to a compound of formula 9

wherein R 1 and R 2 are independently selected from the group consisting of hydrogen, C 1 -C 10 alkyl, aryl, C 1 -C 10 aralkyl; R 3 is cinnamoyl or heteroaryl; and R 4 is selected from the group consisting of hydrogen, alkyl, aryl, aralkyl, benzoyl, cinnamoyl, and heteroaryl.

2. The process according to claim 1 , wherein the step of converting the compound of formula 17 to the compound of formula 16 is performed in the presence of a thionyl chloride and a base.

3. The process according to claim 2 , wherein the base is selected from the group consisting of alkali metal hydroxides, alkali metal carbonates, amine bases, alcoholic amine bases, and mixtures thereof.

4. The process according to claim 1 , wherein the oxidizing agent is selected from the group consisting of sodium hypochlorite, peroxides, and mixtures thereof.

5. The process according to claim 1 , wherein the compound of formula 17 may be directly converted to the compound of formula 15 by reacting the compound of formula 17 with a sulfonating agent in the presence of a base.

6. The process according to claim 5 , wherein the sulfonating agent selected from the group consisting of sulfuryl chloride, sulfuryl fluoride, and mixtures thereof.

7. The process according to claim 5 wherein the base is selected from the group consisting of alkali metal hydroxides, alkali metal carbonates, amine bases, alcoholic amine bases and mixtures thereof.

8. The process according to claim 1 , wherein the step of fluorinating the compound of formula 15 to the compound of formula 14 is performed in the presence of a fluorinating agent.

9. The process according to claim 7 , wherein the fluorinating agent is selected from the group consisting of hydrogen fluoride, tetraethylammonium fluoride, tetrabutylammonium fluoride, and mixtures thereof.

10. The process according to claim 1 , wherein the hydrolyzing of formula 14 is carried out in the presence of an acid.

11. The process according to claim 9 , wherein the acid is selected from the group consisting of hydrochloric acid, hydrobromic acid, sulfuric acid, formic acid, acetic acid, fumaric acid, oxalic acid, and mixtures thereof.

12. The process according to claim 1 , wherein the step of converting the compound of formula 12 to the compound of formula 9 is performed in the presence of an acid.

13. The process according to claim 11 , wherein acid is selected from the group consisting of hydrochloric acid, hydrobromic acid, sulfuric acid, formic acid, acetic acid, trifluoro acetic acid, fumaric acid, oxalic acid, and mixtures thereof.

14. The process according to claim 1 , further comprising converting the compound of formula 9 into sofosbuvir.

15. A compound of formula 12a

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2024
From: MYLAN LABORATORIES LIMITED
To: TIANISH LABORATORIES PRIVATE LIMITED
Reel/Frame 068861/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2019
From: JAYACHANDRA, SURESHBABU; RAO, POTLA VENKATA SRINIVASA; DEV, VIKAS CHANDRA; KOTTOLLA, SAIPRASAD; KAUSHIK, VIPIN KUMAR; DANDALA, SUBRAMANYAM; RAVI, VIJAYA KRISHNA; MUGGU, CHAITANYA; VAKITI, SRINIVAS
To: MYLAN LABORATORIES LIMITED
Reel/Frame 048557/0182 →
Priority Claims (1)
IN 5940/CHE/2015 · Nov 3, 2015 · national
Continuity (1)
Related Publication 20180312484A1 · Nov 1, 2018